Products for Research Use Only

Zoledronic acid (monohydrate) (Standard)

CAT: 0804-HY-13777AR-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13777AR-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Zoledronic acid (monohydrate) (Standard) is the analytical standard of Zoledronic acid (monohydrate) . This product is intended for research and analytical applications. Zoledronic acid monohydrate (Zoledronate monohydrate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic acid monohydrate inhibits the differentiation and apoptosis of osteoclasts. Zoledronic acid monohydrate also has anti-cancer effects[1].
CAS Number
165800-06-6
Product Name Alternative
Zoledronate monohydrate (Standard) ; CGP 42446 monohydrate (Standard) ; CGP42446A monohydrate (Standard) ; ZOL 446 monohydrate (Standard)
UNSPSC
12352005
Target
Apoptosis; Autophagy; Bacterial; Reference Standards
Type
Reference Standards
Related Pathways
Anti-infection; Apoptosis; Autophagy; Others
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/zoledronic-acid-monohydrate-standard.html
Smiles
OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1.[H]O[H]
Molecular Formula
C5H12N2O8P2
Molecular Weight
290.10
References & Citations
[1]Lianwei Wang, et al. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer. 2020; 20: 1059.|[2]Hyung Joon Kim, et al. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis. Int J Mol Sci. 2019 Mar; 20 (6) : 1467.|[3]Xiao-Lin Huang, et al. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways. Int J Mol Med. 2019 Aug;44 (2) :582-592.|[4]XIN HUANG, et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. 2016 Jan; 13 (1) : 613-622.|[5]Samantha Pozzi, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009 Sep 15;15 (18) :5829-39.|[6]Shea GKH, et al. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial. J Orthop Res. 2022 Feb 23.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards

Chemical Information

Zoledronic acid monohydrate

See also: Zoledronic Acid (annotation moved to).

CAS Number165800-06-6
PubChem CID121586
IUPAC Name(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;hydrate
Molecular FormulaC5H12N2O8P2
Molecular Weight290.11
Topological Polar Surface Area154
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count9
Rotatable Bond Count4
Heavy Atom Count17
Formal Charge0
Complexity327
SMILES
C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
InChI
InChI=1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChIKey
FUXFIVRTGHOMSO-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Zoledronic acid monohydrate
CAS: 165800-06-6
CID: 121586
Formula: C5H12N2O8P2
MW: 290.11
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight290.11
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count9
Rotatable Bond Count4
Exact Mass290.00688934
Monoisotopic Mass290.00688934
Topological Polar Surface Area154 Ų
Heavy Atom Count17
Formal Charge0
Complexity327
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes